- Home
- The Outlook for Pharmaceuticals in South East Asia
The Outlook for Pharmaceuticals in South East Asia
This market research, not available anymore on the publisher's website, was withdrawn from our database.
To get an alternative report, you can either :
- Have a look at the list of documents hereafter
- Launch a new search below
Search ReportLinker
The Largest Collection of Market Research Reports
» 450,000 Company Profiles
» 40,000 Country Guides
From +200,000 authoritative sources
DOWNLOAD THESE REPORTS NOW!
Vaccine Market in Singapore
- $ 652
- Industry report
- by Global Research & Data Services
- May 2013
- 19 pages
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in Singapore. The study provides essential market information for decision-makers including: - Overall market for vaccines in Singapore - Market for vaccines by type - Forecasts and ...
Industries: Drug and Medication | Countries: Singapore
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
- $ 3 500
- Industry report
- by GBI Research
- April 2013
- 137 pages
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants Summary GBI Research, the leading business intelligence provider has released its latest research ...
Industries: Drug and Medication | Countries: Philippines, Singapore, New Zealand, Australia, Malaysia, Taiwan, Japan, China, Asia, India, Oceania, World
Singapore Pharmaceuticals and Healthcare Industry Update Quarter 2 2012
- $ 1 088
- Industry report
- by Business Monitor International
- February 2013
- 114 pages
BMI View: Singapore is a well-developed pharmaceutical industry, although overall revenues only reached a modest SGD901mn (US Dollar 716mn) in 2011, on account of the small population of the city-state. Nevertheless, the government will continue to prioritise research and biomedical manufacturing, which ...
Industries: Drug and Medication | Countries: Singapore
The Pharmaceutical Market: Singapore, Business Monitor International
- $ 1 266
- Industry report
- by Business Monitor International
- January 2013
- 112 pages
Espicom market intelligence, brought to you by Business Monitor International OVERVIEW OF THE PHARMACEUTICAL MARKET IN SINGAPORE Singapore will be of moderate attractiveness to investors given its small pharmaceutical market size, despite the growing demands for more pharmaceuticals and healthcare from ...
Industries: Drug and Medication | Countries: Singapore
The Pharmaceutical Market: Hong Kong, Business Monitor International
- $ 1 266
- Industry report
- by Business Monitor International
- January 2013
- 91 pages
Espicom market intelligence, brought to you by Business Monitor International THE PHARMACEUTICAL MARKET: HONG KONG - REVIEW Hong Kong will continue to attract pharmaceutical investors' interest due to the population's affluence and its close proximity to China. However, we caution that the lack of significant ...
Industries: Drug and Medication | Countries: China, South Korea, Asia, Philippines, United States, Singapore, Indonesia, Taiwan, Malaysia, World
PT Tempo Scan Pacific Tbk (TSPC) - Financial and Strategic SWOT Analysis Review
- $ 125
- Company report
- by Global Data
- November 2012
- 32 pages
Summary PT Tempo Scan Pacific Tbk, formerly known as PT Scanchemie is a pharmaceutical company. It undertakes the manufacturing, commercialization and distribution of pharmaceuticals and consumer and health products. The company's key product portfolio includes Pharmaceutical division, Prescription products ...
Industries: Drug and Medication | Countries: Indonesia, Philippines, Singapore
Singapore Business Projection Industry Update Quarter 4 2011
- $ 1 050
- Industry report
- by Business Monitor International
- October 2012
- 49 pages
Core Views Singapore's real Gross Domestic Product expansion will most likely slow considerably from the 14.5% high registered in 2010, owing to a slowdown in global trade flows as well as the strengthening of the Singapore dollar. These factors should place downward pressure on headline growth, which ...
Industries: Drug and Medication | Countries: Singapore
Antibiotics Market in Singapore to 2016
- $ 652
- Industry report
- by Global Research & Data Services
- September 2012
- 42 pages
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Singapore. The study provides essential market information for decision-makers including: - Overall market value for antibiotics in Singapore - Overall market volume for antibiotics ...
Industries: Drug and Medication | Countries: Singapore
Pathology Industry: YM BioSciences Inc. ? Product Pipeline Review - H2 2011
- $ 1 500
- Company report
- by Global Markets Direct
- August 2012
- 71 pages
- Product Pipeline Review - H2 2011? provides a detailed overview on the YM BioSciences Inc.?s research and development focus. The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and ...
Industries: Drug and Medication | Countries: United States, World, Canada, Singapore
Digestive Remedies Market Overview in Singapore
- $ 898
- Industry report
- by Euromonitor International
- June 2012
- 22 pages
Digestive remedies saw value sales growth in 2010, mainly due to the increase in population. Consumers tend to rely on brands they are familiar with and are reluctant to try new products. For instance, the well-known Po Chai Pills brand, which is industry ed by Li Chung Shing Tong (Holdings) Ltd, saw ...
Industries: Drug and Medication | Countries: Singapore
24/7 Customer Service
You can call our customer service 24 hours a day / 7 days a week
- 00 1 718 618 48 97
ref:plp2012
Reportlinker.com © Copyright 2013. All rights reserved.
